| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| 10/21/2026 | ±2.9% | +1.2% | over-priced |
| 07/23/2026 | ±3.0% | -3.6% | under-priced |
| 04/23/2026 | ±2.8% | -3.1% | under-priced |
| 02/18/2026 | ±4.6% | +6.5% | under-priced |
| 10/23/2025 | ±2.5% | +1.4% | over-priced |
| 07/24/2025 | ±2.5% | +1.0% | over-priced |
| 04/23/2025 | ±3.4% | +0.2% | over-priced |
| 02/14/2025 | ±2.3% | -0.9% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q3 FY2026 | $4.24 | $2.0B | $734M |
| Q2 FY2026 | $5.03 | $2.2B | $878M |
| Q1 FY2026 | $3.73 | $2.1B | $661M |
| Q4 FY2025 | — | $1.9B | $610M |
MCO (MCO) reports in 83 days, with the next report estimated for 01/19/2027. Across the last 8 reports, options priced an average ±3.0% earnings move while the stock actually moved 2.2% on average — the market has been roughly fair on MCO's earnings risk. Fundamentals into the print: EPS up 17.8% year-over-year, revenue up 0.8%. QuantLogix's live 5-factor engine currently reads MCO as a buy at 87/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →